Login / Signup

Inter-rater variability in patch test readings and final interpretation using store-forward teledermatology.

Molly C GoodierJoel G DeKovenJames S TaylorDennis SassevilleJoseph F FowlerAnthony F FranswayVincent A DeLeoJames G MarksKathryn A ZugSara A HylwaErin M Warshaw
Published in: Contact dermatitis (2021)
For patch testing, teledermatology has significant limitations including clinically significant pooled failure percentages of 13.6% for second readings and 24.6% for final interpretation.
Keyphrases
  • skin cancer
  • randomized controlled trial
  • open label
  • study protocol